Propel Bio Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-228,884
| Closed | -$10.9M | – | 21 |
|
|
2025
Q3 | $10.9M | Hold |
228,884
| – | – | 10.88% | 3 |
|
|
2025
Q2 | $12.2M | Hold |
228,884
| – | – | 14.82% | 3 |
|
|
2025
Q1 | $9.27M | Sell |
228,884
-114,845
| -33% | -$4.87M | 10.76% | 3 |
|
|
2024
Q4 | $9.56M | Hold |
343,729
| – | – | 9.5% | 3 |
|
|
2024
Q3 | $9.86M | Buy |
343,729
+15,977
| +5% | +$417K | 5.72% | 6 |
|
|
2024
Q2 | $7.69M | Hold |
327,752
| – | – | 4.99% | 7 |
|
|
2024
Q1 | $8.28M | Buy |
327,752
+227,700
| +228% | +$5.47M | 4.82% | 7 |
|
|
2023
Q4 | $2.34M | Buy |
+100,052
| New | +$1.97M | 1.94% | 14 |
|
